TNFSF9 Is a Prognostic Biomarker and Correlated with Immune Infiltrates in Pancreatic Cancer

被引:23
作者
Wu, Jiao [1 ]
Wang, Yunpeng [2 ]
Jiang, Zheng [1 ]
机构
[1] Chongqing Med Univ, Dept Gastroenterol, Affiliated Hosp 1, Chongqing 400016, Peoples R China
[2] Zigong First Peoples Hosp, Dept Cardiovasc, Zigong 643000, Sichuan, Peoples R China
关键词
TNFSF9; Lymphocytes; Macrophages; Prognosis; Pancreatic cancer; GENE-EXPRESSION; CD137; LIGAND; ANTITUMOR RESPONSE; T-LYMPHOCYTES; WEB SERVER; TUMOR; CELLS; SURVIVAL; POLARIZATION; ACTIVATION;
D O I
10.1007/s12029-020-00371-6
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background TNFSF9 gene has been found to play an anti-tumor role and regulate the function of immune cells. However, the prognostic role of TNFSF9 in pancreatic cancer and its relationship with immune cell infiltration have not been studied. Methods We used Oncomine, UALCAN, and GEPIA databases to analyze the expression of TNFSF9 in pancreatic cancer. We used Kaplan-Meier plotters, GEPIA, and UALCAN to evaluate the effect of TNFSF9 on clinical prognosis. We further used TIMER to study the correlation between TNFSF9 and cancer immune infiltrate cells. In addition, we used GEPIA to analyze the correlation between TNFSF9 expression and gene markers of immune infiltrate cells. Results TNFSF9 mRNA expression level was remarkably increased in pancreatic cancer than that in normal tissues (both P < 0.05). In addition, high TNFSF9 expression was significantly related to poor overall survival (OS) and relapse-free survival (RFS) in pancreatic cancer (OS HR = 2.02, P = 0.0012; RFS HR = 2.63, P = 0.022). Moreover, high TNFSF9 expression in pancreatic cancer patients was associated with worse OS in stage 1 to 2 but not stage 3 and stage 4. Specifically, TNFSF9 expression and CD8(+) T cell infiltration of pancreatic cancer was negatively correlated. TNFSF9 expression showed strong correlations with M1 macrophages in pancreatic cancer. Conclusions Our results suggest that TNFSF9 is associated with prognosis and CD8(+) T cell infiltration levels in patients with pancreatic cancer. Further, TNFSF9 expression potentially contributes to the modulation of M1 polarization of macrophages. These findings indicate that TNFSF9 can be serves as a prognostic biomarker in determining the prognosis of pancreatic cancer and is associated with different types of phenotypes of immune cell infiltration.
引用
收藏
页码:150 / 159
页数:10
相关论文
共 46 条
[1]   Calcitriol Decreases Expression of Importin α3 and Attenuates RelA Translocation in Human Bronchial Smooth Muscle Cells [J].
Agrawal, Tanupriya ;
Gupta, Gaurav K. ;
Agrawal, Devendra K. .
JOURNAL OF CLINICAL IMMUNOLOGY, 2012, 32 (05) :1093-1103
[2]   Tumor-Infiltrating Lymphocyte Grade Is an Independent Predictor of Sentinel Lymph Node Status and Survival in Patients With Cutaneous Melanoma [J].
Azimi, Farhad ;
Scolyer, Richard A. ;
Rumcheva, Pavlina ;
Moncrieff, Marc ;
Murali, Rajmohan ;
McCarthy, Stanley W. ;
Saw, Robyn P. ;
Thompson, John F. .
JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (21) :2678-2683
[3]   Normalizing Microbiota-Induced Retinoic Acid Deficiency Stimulates Protective CD8+ T Cell-Mediated Immunity in Colorectal Cancer [J].
Bhattacharya, Nupur ;
Yuan, Robert ;
Prestwood, Tyler R. ;
Penny, Hweixian Leong ;
DiMaio, Michael A. ;
Reticker-Flynn, Nathan E. ;
Krois, Charles R. ;
Kenkel, Justin A. ;
Pham, Tho D. ;
Carmi, Yaron ;
Tolentino, Lorna ;
Choi, Okmi ;
Hulett, Reyna ;
Wang, Jinshan ;
Winer, Daniel A. ;
Napoli, Joseph L. ;
Engleman, Edgar G. .
IMMUNITY, 2016, 45 (03) :641-655
[4]   Toward personalized TGFβ inhibition for pancreatic cancer [J].
Carr, Ryan M. ;
Fernandez-Zapico, Martin E. .
EMBO MOLECULAR MEDICINE, 2019, 11 (11)
[5]   UALCAN: A Portal for Facilitating Tumor Subgroup Gene Expression and Survival Analyses [J].
Chandrashekar, Darshan S. ;
Bashel, Bhuwan ;
Balasubramanya, Sai Akshaya Hodigere ;
Creighton, Chad J. ;
Ponce-Rodriguez, Israel ;
Chakravarthi, Balabhadrapatruni V. S. K. ;
Varambally, Sooryanarayana .
NEOPLASIA, 2017, 19 (08) :649-658
[6]   NLRP3 signaling drives macrophage-induced adaptive immune suppression in pancreatic carcinoma [J].
Daley, Donnele ;
Mani, Vishnu R. ;
Mohan, Navyatha ;
Akkad, Neha ;
Pandian, Gautam S. D. Balasubramania ;
Savadkar, Shivraj ;
Lee, Ki Buom ;
Torres-Hernandez, Alejandro ;
Aykut, Berk ;
Diskin, Brian ;
Wang, Wei ;
Farooq, Mohammad S. ;
Mahmud, Arif I. ;
Werba, Gregor ;
Morales, Eduardo J. ;
Lall, Sarah ;
Wadowski, Benjamin J. ;
Rubin, Amanda G. ;
Berman, Matthew E. ;
Narayanan, Rajkishen ;
Hundeyin, Mautin ;
Miller, George .
JOURNAL OF EXPERIMENTAL MEDICINE, 2017, 214 (06) :1711-1724
[7]   Intratumor T helper type 2 cell infiltrate correlates with cancer-associated fibroblast thymic stromal lymphopoietin production and reduced survival in pancreatic cancer [J].
De Monte, Lucia ;
Reni, Michele ;
Tassi, Elena ;
Clavenna, Daniela ;
Papa, Ilenia ;
Recalde, Helios ;
Braga, Marco ;
Di Carlo, Valerio ;
Doglioni, Claudio ;
Protti, Maria Pia .
JOURNAL OF EXPERIMENTAL MEDICINE, 2011, 208 (03) :469-478
[8]   The re-polarisation of M2 and M1 macrophages and its role on cancer outcomes [J].
den Breems, Nicoline Y. ;
Eftimie, Raluca .
JOURNAL OF THEORETICAL BIOLOGY, 2016, 390 :23-39
[9]   Gemcitabine treatment promotes immunosuppressive microenvironment in pancreatic tumors by supporting the infiltration, growth, and polarization of macrophages [J].
Deshmukh, Sachin Kumar ;
Tyagi, Nikhil ;
Khan, Mohammad Aslam ;
Srivastava, Sanjeev Kumar ;
Al-Ghadhban, Ahmed ;
Dugger, Kari ;
Carter, James Elliot ;
Singh, Seema ;
Singh, Ajay Pratap .
SCIENTIFIC REPORTS, 2018, 8
[10]   CD137 and CD137L signals are main drivers of type 1, cell-mediated immune responses [J].
Dharmadhikari, Bhushan ;
Wu, Meihui ;
Abdullah, Nur Sharalyn ;
Rajendran, Sakthi ;
Ishak, Nur Diana ;
Nickles, Emily ;
Harfuddin, Zulkarnain ;
Schwarz, Herbert .
ONCOIMMUNOLOGY, 2016, 5 (04)